Companies: 10,795·Total market cap: $144.5T

Bicycle Therapeutics plc

Bicycle Therapeutics plc

BCYCNASDAQHealthcare● Active

$4.20

$-0.07(-1.64%)

Market Cap$291457047

P/E Ratio—

52W High$9.36

52W Low$4.075

Avg Volume434K

Open$4.28

Beta1.54

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Bicycle Therapeutics plc（BCYC）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · BCYC · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-3.15Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$63.5MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding69.3MShares outstanding history

Next EarningsAug 14, 2026Est.Earnings history

探索 Bicycle Therapeutics plc 数据

分析师预测$11 · Buy

股息不分红

营收$72.6M+105.77%

盈利EPS $-3.16-8.59%

财务快照

FY 2025Revenue$72.6M▲ +105.77% YoY

202320242025

FY 2025Net Income-$219.0M▼ 29.54% YoY

202320242025

FY 2025EPS$-3.16▼ 8.59% YoY

202320242025

TTM:Revenue: $63.5MNet Income: -$219.0MEPS: $-3.15View income statement →

分析师评级与目标价

Buy21 位分析师

Strong Buy

0

Buy

17

Hold

4

Sell

0

Strong Sell

0

12-Month Price Target

$8.00Low

$4.20Current

$10.67Avg Target上涨空间 154.05%

$12.00High

合计: 21 · 买入占比: 81.0%

根据过去 3 个月内 21 位华尔街分析师，BCYC 共识评级为 Buy，12 个月平均目标价 $10.67 （较现价 $4.20 上涨空间 154.05%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Bicycle Therapeutics plc

$4.20-1.64%$291.5M #2

ADC Therapeutics S.A.

$1.03-21.97%$131.0M #3

Compass Therapeutics, Inc.

$2.04-4.23%$282.1M #4

4D Molecular Therapeutics, Inc.

$8.64-13.69%$451.7M #5

Fulcrum Therapeutics, Inc.

$3.69+9.50%$199.7M #6

KalVista Pharmaceuticals, Inc.

$26.95+0.00%$1.4B

股票表现

1D-1.64%

1W-2.33%

1M-12.68%

3M-19.23%

YTD-40.68%

1Y-50.82%

5Y-86.05%

关于 Bicycle Therapeutics plc

CEOKevin Lee

IPO DateMay 23, 2019

Employees305

CountryGB

Websitebicycletherapeutics.com

Bicycle Therapeutics plc a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a …

Biotechnology HealthcareNASDAQADRGB

关于股票概览与关键数据

Bicycle Therapeutics plc（BCYC）是 Biotechnology 行业的 Healthcare 类公司，于 May 23, 2019 在 NASDAQ 上市。截至最近交易日，BCYC 股价为 $4.20，市值约为 $291.5M。过去12个月累计回报 -50.82%，年初至今回报 -40.68%。

根据 21 位华尔街分析师，Bicycle Therapeutics plc 股票共识评级为Buy，12个月平均目标价为 $10.67。2025 财年 Bicycle Therapeutics plc 营收 $72.6M，净利润 -$219.0M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Bicycle Therapeutics plc（BCYC）股价为 $4.20，在 NASDAQ 上市，52周区间为 $4.08 – $9.36。

BCYC 最新股价BCYC quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议